71
Participants
Start Date
June 19, 2023
Primary Completion Date
August 8, 2024
Study Completion Date
August 8, 2024
INS018_055
"Pharmaceutical formulation: Capsules~Mode of Administration: Oral"
Placebo
"Pharmaceutical formulation: Capsules~Mode of Administration: Oral"
Peking University Shougang Hospital, Beijing
Beijing Friendship Hospital, Capital Medical University, Beijing
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing
The Shengjing Hospital of China medical university, Shenyang
Shanghai Chest Hospital, Shanghai
Zhongshan hospital Fudan University, Shanghai
Shanghai Pulmonary Hospital, Shanghai
Nanjing Drum Tower Hospital, Nanjing
Anhui Chest Hospital, Hefei
The Second Affiliated Hospital of Anhui Medical University, Hefei
Qilu Hospital of Shandong University, Jinan
General Hospital of Tianjin Medical University, Tianjin
The First Affiliated Hospital - Zhejiang University School of Medicine, Hangzhou
Jiangxi Provincial People's Hospital, Nanchang
Xiangya Hospital of Central South University, Changsha
The Second Xiangya Hospital of Central South University, Changsha
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou
Nanfang Hospital of Southern Medical University, Guangzhou
Hainan General Hoapital, Haikou
The West China Hospital of Sichuan University, Chengdu
Shanxi Bethune Hospital, Taiyuan
InSilico Medicine Hong Kong Limited
INDUSTRY